Decision support reduces antibiotic usage for bronchitis

January 15, 2013 in Diseases, Conditions, Syndromes

Decision support reduces antibiotic usage for bronchitis

Decision support strategies can help reduce the over-prescription of antibiotics for acute bronchitis in primary care settings, according to a study published online Jan. 14 in JAMA Internal Medicine.

(HealthDay)—Decision support strategies can help reduce the over-prescription of antibiotics for acute bronchitis in primary care settings, according to a study published online Jan. 14 in JAMA Internal Medicine.

Ralph Gonzales, M.D., M.S.P.H., from the University of California in San Francisco, and colleagues compared the effect of two decision support strategies on of uncomplicated acute bronchitis in a randomized study involving 33 primary care practices in an integrated . The practices were randomized in a 1:1:1 ratio to receive printed decision support for acute cough illness, computer-assisted decision support through , or control sites. Intervention sites also received clinician education and feedback on prescribing practices as well as patient education brochures. Antibiotic prescription rates were compared for the winter period following introduction of the intervention and the previous three winter periods.

The researchers found that during the intervention period the percentage of adolescents and adults prescribed antibiotics declined at the printed decision and computer-assisted support sites (from 80.0 to 68.3 percent and from 74.0 to 60.7 percent, respectively), while at control sites there was a slight increase (from 72.5 to 74.3 percent). The differences in prescribing at the intervention sites were significant compared to the control sites, after adjustment for patient and clinician characteristics. There were no significant other differences between the intervention sites.

"In conclusion, an evidence-based algorithm to guide management of acute bronchitis can reduce the in primary care settings, but the mode of implementation does not seem to influence the magnitude of effect," the authors write.

Two authors disclosed financial ties to the pharmaceutical and medical informatics industries.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Journal reference: JAMA Internal Medicine search and more info website

Copyright © 2013 HealthDay. All rights reserved.

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

FDA warns of infections tied to Tennessee pharmacy

(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity not rated yet | comments 0

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity not rated yet | comments 0

Top-ranked golfer beats scoliosis

(HealthDay)—As a world-class golfer, Stacy Lewis' accomplishments are remarkable. But it was a physical challenge in her childhood that defined her ascent to the top of her sport.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity not rated yet | comments 0

Saudi to send animal samples to US in coronavirus probe (Update)

Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity not rated yet | comments 0

WHO voices deep concern over spread of SARS-like virus

The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity 5 / 5 (1) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.